Research graph
References from Monocyte-to-HDL cholesterol ratio and cardiovascular comorbidity in COPD. Local targets link to admitted publications; unresolved targets remain external evidence.
Chronic obstructive pulmonary disease.
10.1016/s0140-6736(22)00470-6 · 2022 · External reference
GOLD COPD report: 2024 update.
10.1016/s2213-2600(23)00461-7 · 2024 · External reference
Cardiovascular disease and risk in COPD: a state of the art review.
10.1080/14779072.2024.2333786 · 2024 · External reference
Role of alveolar macrophages in chronic obstructive pulmonary disease.
10.3389/fimmu.2014.00435 · 2014 · External reference
Cardiovascular diseases in COPD: from diagnosis and prevalence to therapy.
2023 · External reference
Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population.
10.3389/fendo.2022.944991 · 2022 · External reference
Monocyte to high-density lipoprotein ratio predict long-term clinical outcomes in patients with coronary heart disease: a meta-analysis of 9 studies.
10.1097/md.0000000000030109 · 2022 · External reference
Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the United States.
10.1186/s12944-022-01638-6 · 2022 · External reference
National Health and Nutrition Examination Survey, 2015–2018: sample design and estimation procedures.
2020 · External reference
Relationship between the monocyte-to-HDL-C ratio (MHR) and COPD: a cross-sectional study based on NHANES 2009–2018.
2025 · External reference
Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians.
10.1038/s41409-019-0679-x · 2020 · External reference
Adjustment of the GRACE risk score by monocyte to high-density lipoprotein ratio improves prediction of adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
10.3389/fcvm.2021.755806 · 2021 · External reference
Evaluation of the prognosis of elderly patients with heart failure by monocyte-to-high-density lipoprotein ratio, neutrophil gelatinase-associated lipocalin, and angiotensin II.
10.3389/fcvm.2025.1609798 · 2025 · External reference
Monocyte to high-density lipoprotein ratio predicts clinical outcomes after acute ischemic stroke or transient ischemic attack.
10.1111/cns.14152 · 2023 · External reference
Monocyte to high-density lipoprotein ratio is associated with mortality in patients with coronary artery diseases.
10.1186/s12872-023-03461-y · 2023 · External reference
Could monocyte level/HDL cholesterol ratio predict cardiovascular diseases in patients with COPD?
10.4103/njcp.njcp_54_19 · 2020 · External reference
Comorbidities in COPD: current and future treatment challenges.
10.3390/jcm13030743 · 2024 · External reference
Dysfunctional high-density lipoprotein cholesterol and coronary artery disease: a narrative review.
10.3390/jpm14090996 · 2024 · External reference
High-density lipoproteins: a role in inflammation in COPD.
10.3390/ijms23158128 · 2022 · External reference
The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk.
10.1186/s12944-017-0594-3 · 2017 · External reference
The effect of statin therapy on inflammatory biomarkers: a systematic review.
2021 · External reference
Reliability and validity of self-reported vascular risk factors: hypertension, diabetes, and heart disease, in a multi-ethnic community based study of aging and dementia.
10.3233/jad-230374 · 2023 · External reference
The importance of appropriate diagnosis in the practical management of chronic obstructive pulmonary disease.
10.3390/diagnostics11040618 · 2021 · External reference
Chronic obstructive pulmonary disease.
10.1016/s0140-6736(22)00470-6 · ExternalCitation · doi-reference
GOLD COPD report: 2024 update.
10.1016/s2213-2600(23)00461-7 · ExternalCitation · doi-reference
Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians.
10.1038/s41409-019-0679-x · ExternalCitation · doi-reference
Cardiovascular disease and risk in COPD: a state of the art review.
10.1080/14779072.2024.2333786 · ExternalCitation · doi-reference
Monocyte to high-density lipoprotein ratio predict long-term clinical outcomes in patients with coronary heart disease: a meta-analysis of 9 studies.
10.1097/md.0000000000030109 · ExternalCitation · doi-reference
Monocyte to high-density lipoprotein ratio predicts clinical outcomes after acute ischemic stroke or transient ischemic attack.
10.1111/cns.14152 · ExternalCitation · doi-reference
Monocyte to high-density lipoprotein ratio is associated with mortality in patients with coronary artery diseases.
10.1186/s12872-023-03461-y · ExternalCitation · doi-reference
The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk.
10.1186/s12944-017-0594-3 · ExternalCitation · doi-reference
Monocyte-to-high-density lipoprotein-cholesterol ratio (MHR) and the risk of all-cause and cardiovascular mortality: a nationwide cohort study in the United States.
10.1186/s12944-022-01638-6 · ExternalCitation · doi-reference
Reliability and validity of self-reported vascular risk factors: hypertension, diabetes, and heart disease, in a multi-ethnic community based study of aging and dementia.
10.3233/jad-230374 · ExternalCitation · doi-reference
Adjustment of the GRACE risk score by monocyte to high-density lipoprotein ratio improves prediction of adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
10.3389/fcvm.2021.755806 · ExternalCitation · doi-reference
Evaluation of the prognosis of elderly patients with heart failure by monocyte-to-high-density lipoprotein ratio, neutrophil gelatinase-associated lipocalin, and angiotensin II.
10.3389/fcvm.2025.1609798 · ExternalCitation · doi-reference
Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population.
10.3389/fendo.2022.944991 · ExternalCitation · doi-reference
Role of alveolar macrophages in chronic obstructive pulmonary disease.
10.3389/fimmu.2014.00435 · ExternalCitation · doi-reference
The importance of appropriate diagnosis in the practical management of chronic obstructive pulmonary disease.
10.3390/diagnostics11040618 · ExternalCitation · doi-reference
High-density lipoproteins: a role in inflammation in COPD.
10.3390/ijms23158128 · ExternalCitation · doi-reference
Comorbidities in COPD: current and future treatment challenges.
10.3390/jcm13030743 · ExternalCitation · doi-reference
Dysfunctional high-density lipoprotein cholesterol and coronary artery disease: a narrative review.
10.3390/jpm14090996 · ExternalCitation · doi-reference
Could monocyte level/HDL cholesterol ratio predict cardiovascular diseases in patients with COPD?
10.4103/njcp.njcp_54_19 · ExternalCitation · doi-reference
